On the interstate, when traffic suddenly slows, often you come across the obvious cause of the jam: a fender bender, construction, a breakdown. But in trying to understand why the country’s pharmaceutical, biotech and medical device sectors seem to be facing a slowdown in terms of innovation, there is no single cause.
It’s likely that this slowdown is due to a combination of many factors. And while these industries have fared better than others, it is critical for the health and well being of every American that they not just survive, but thrive.
That’s why we want the Food and Drug Administration (FDA) to do everything we can to promote innovation.
Today the FDA is an agency that works with industry to ensure that a wide array of products that improve the lives of millions of Americans are safe and effective. We do that well, and I am personally proud of that.
But we have also been listening closely to companies, patients, doctors and advocacy groups about ways we can help America remain the leader in biomedical innovation. The FDA’s suggestion box is never closed. And, as you can imagine, never empty.
Fonte: White House